https://www.selleckchem.com/products/r16.html
When compared with sham controls, high phosphorus CKD rats were shown to be hyperphosphatemic (4.11 ± 0.23 versus 2.41 ± 0.22 mM Pi, p less then 0.0001) with elevated total plasma MVs (2.24 ± 0.37 versus 1.31 ± 0.24 × 108 per ml, p less then 0.01), showing increased CD144 expression (145 ± 25% of control value, p less then 0.0001), and enhanced procoagulant activity (18.06 ± 1.75 versus 4.99 ± 1.77 nM peak thrombin, p less then 0.0001). These effects were abolished in the low phosphorus CKD group. In this rat model, hyperphosphatemia (or a
Like
Comment
Share
